Similar articles

• Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.

  Yamamoto T, Umegae S, Matsumoto K. Yamamoto T, et al. Inflamm Bowel Dis. 2009 Oct;15(10):1460-6. doi: 10.1002/ibd.20915. Inflamm Bowel Dis. 2009. PMID: 19266566 Clinical Trial.
• Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.

  Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, Federico F, De Vitis I, Rapaccini GL, Guidi L. Armuzzi A, et al. J Crohns Colitis. 2013 Dec;7(12):e623-9. doi: 10.1016/j.crohns.2013.04.020. Epub 2013 Jun 27. J Crohns Colitis. 2013. PMID: 23810678 Clinical Trial.
• Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.

  Magro F, Santos-Antunes J, Vilas-Boas F, Rodrigues-Pinto E, Coelho R, Ribeiro OS, Lopes S, Macedo G. Magro F, et al. J Crohns Colitis. 2014 Jul;8(7):617-25. doi: 10.1016/j.crohns.2013.11.020. Epub 2013 Dec 12. J Crohns Colitis. 2014. PMID: 24332869
• [Drug therapy of Crohn disease].

  Niemelä S. Niemelä S. Duodecim. 2001;117(8):807-14. Duodecim. 2001. PMID: 12116446 Review. Finnish. No abstract available.
• Prevention of postoperative recurrence of Crohn's disease.

  van Loo ES, Dijkstra G, Ploeg RJ, Nieuwenhuijs VB. van Loo ES, et al. J Crohns Colitis. 2012 Jul;6(6):637-46. doi: 10.1016/j.crohns.2011.12.006. Epub 2012 Jan 9. J Crohns Colitis. 2012. PMID: 22398096 Review.